Icecure Medical is trading at $1.78, up 10.22% in after-hours trading, with no clear company-specific catalyst identified for the September 30, 2026 rise.
- Recent company news does not establish a direct connection to the move.
- Icecure Medical’s China regulatory approval was announced September 10, not September 30.
- Broader market signals were mixed, and available evidence does not clearly explain the move as market-driven.